U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917156) titled 'New Italian Mastocytosis Registry' on Oct. 30.
Brief Summary: This study will involve 27 centers in Italy. Since this is a multidisciplinary disease, participating centers may be from various medical areas (hematology, dermatology, allergy, etc.).
The study will last 10 years. The first patient is estimated to be enrolled in January 2021, while the last patient is expected to be completed in January 2031.
This is a retrospective and prospective registry. Since no intervention is foreseen, it can be considered an observational study.
The primary objective is to understand the clinical implications of mastocytosis, including the nat...